Genetic Testing in Prenatal and Newborn Screening
Genetic Testing plays a crucial role in prenatal care by identifying potential genetic disorders before a baby is born. Techniques like non-invasive prenatal testing (NIPT) can detect chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome using just a maternal blood sample. This early detection empowers parents to make informed decisions about pregnancy management and prepare for specialized medical care if needed. Prenatal genetic testing also helps identify rare metabolic disorders, allowing for immediate treatment after birth to prevent complications.
In newborn screening, Genetic Testing is conducted shortly after delivery to check for inherited conditions like cystic fibrosis, sickle cell anemia, and phenylketonuria. Early identification means treatment can start right away, significantly improving the child’s health outcomes. With advancements in whole-genome sequencing, newborn screening is evolving into a more comprehensive approach, potentially covering hundreds of genetic conditions and setting the stage for personalized healthcare from the very beginning of life.